相关实验视频

Updated: Jul 15, 2025

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

7.7K

在慢性阻塞性肺病肺部中CD8+ T细胞的激活

Ana B Villaseñor-Altamirano1,2, Dhawal Jain3, Yunju Jeong1,2

  • 1Division of Pulmonary and Critical Care Medicine.

American journal of respiratory and critical care medicine
|September 27, 2023
PubMed

Insights

轻度至中度慢性阻塞性肺病 (COPD) 在肺组织中显示CD8+TEMRA细胞增加. 这些细胞可能会驱动炎症,为预防严重的COPD提供潜在的治疗点.

科学领域:

  • 免疫学 免疫学 免疫学
  • 肺部病理学 肺部病理学
  • 基因组学就是基因组学.

背景情况:

  • 在慢性阻塞性肺病 (COPD) 中,炎症至关重要,但在轻度中度疾病中,免疫细胞格局在单细胞水平上仍然不明朗.
  • 鉴定免疫细胞的特征对于了解疾病进展和开发向疗法至关重要.

研究的目的:

  • 使用单细胞分辨率,从轻度至中度的COPD患者的肺组织中定义免疫细胞格局.
  • 确定特定的免疫细胞种群及其与早期COPD相关的分子特征.

主要方法:

  • 单细胞转录基因,蛋白质基因和T细胞受体谱的分析是在轻度至中度的COPD,肺气血,末期COPD,对照组和供体组的肺组织上进行的.
  • 验证是在一个独立的患者队列 (N=929) 中进行的,并与COPD的小鼠模型集成.

主要成果:

  • 轻度中度COPD肺部表现出两个CD8+T细胞亚群的丰富性增加:细胞毒性KLRG1+TIGIT+CX3CR1+TEMRA细胞和DNAM-1+CCR5+T居住记忆 (TRM) 细胞.
  • 这些CD8+ T细胞通过IFNG与骨髓类和膜类II细胞相互作用,并表现出超扩展的T细胞受体克隆型.
  • 与对照或末期COPD肺相比,轻度至中度的COPD肺部中CD8+ KLRG1+ TEMRA细胞的增加.

结论:

  • 在轻度至中度的COPD肺部中,CD8+TEMRA细胞显著增加,这表明在严重疾病之前的炎症过程中发挥了作用.
  • 对这些CD8+TEMRA细胞的进一步调查可能会揭示预防COPD进展至严重COPD的治疗策略.
抽象的

No abstract available in PubMed .

关键词:
分析RNA序列的分析.慢性阻塞性肺病 慢性阻塞性肺病记忆T细胞 记忆T细胞多种多种多种多种多种多种多种多种多种多种.蛋白质组学 蛋白质组学

更多相关视频

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

9.9K
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.0K

相关概念视频

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
327
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.6K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
787